Title
The significance of biomacromolecule alginate for the 3D printing of hydrogels for biomedical applications
Date Issued
01 July 2022
Access level
metadata only access
Resource Type
review
Author(s)
Universidad San Sebastián
Publisher(s)
Elsevier B.V.
Abstract
Natural biopolymers have been widely employed as biomaterial ink hydrogels for three-dimensional (3D) extrusion bioprinting in the preparation of the next generation of bioengineering materials for healthcare applications. Alginate is a linear anionic polysaccharide with favourable properties, such as: typical rheological (gelling, viscosifying, and stabilizing dispersions) characteristics, biodegradability and biocompatibility properties. However, in order to improve alginate applicability for practical biomaterial/bio ink for advanced medical applications, it is often modified and functionalized with several polymers and nanomaterials in order to obtain better printability of alginate-based biomaterial/bio ink hydrogels. This review, principally, emphasizes the recent developments and with a comprehensive overview of alginate-based biomaterial/bio ink hydrogels and their biomaterials (3D scaffolds, tissue-like structures with hierarchical vasculatures, mimics of biological, physiological and pathological functionalities) for biomedical applications. It also addresses the significance of alginates, oxidized alginate and their functionalizations (interface) with various materials in order to improve the biomaterial/bio ink properties for 3D extrusion bioprinting applications. Finally, it provides current advances, vital roles and new perspectives of alginate-based materials and their future developments for 3D bioprinting purposes.
Start page
561
End page
578
Volume
212
Language
English
OCDE Knowledge area
Biomateriales
Subjects
Scopus EID
2-s2.0-85130976793
PubMed ID
Source
International Journal of Biological Macromolecules
ISSN of the container
0141-8130
Sponsor(s)
Dr. Varaprasad Kokkarachedu acknowledges the support from the Facultad de Ingeniería y Tecnología, Universidad San Sebastián, Sede Concepción and the Fondecyt Regular N o 1211118 , ANID, Chile. Dr. Yallapu acknowledges the support from the Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley and for the NIH grants ( SC1GM139727 ).
Sources of information:
Directorio de Producción Científica
Scopus